The choice between bacteriostatic water (BAC water) and sterile water for injection (SWFI) as a reconstitution solvent for research peptides is one of the most consequential decisions a researcher makes in the lab. The two look identical in the vial, cost roughly the same, and are both compatible with most peptide chemistries. The difference comes down to a single ingredient — benzyl alcohol — and the operational consequences are significant.
Sterile water for injection (SWFI)
SWFI is highly purified water that has been sterilised by autoclaving or filtration. It contains no additives. The USP specification requires SWFI to be pyrogen-free, particulate-free, and to meet stringent conductivity and total organic carbon limits.
The key property: once an SWFI vial is opened, the residual water in the vial has no antimicrobial protection. Any microbial contamination introduced during withdrawal — from a non-sterile syringe, ambient air, or contact with the rubber stopper — will multiply unconstrained. For this reason, SWFI is intended for single-use.
When to use SWFI:
- Single-use experiments where the entire reconstituted volume will be consumed immediately;
- Peptides incompatible with benzyl alcohol (rare but documented for some sensitive proteins);
- Assays where benzyl alcohol’s secondary effects (potential interference with certain receptor binding or membrane studies) must be excluded;
- Sensitive peptides where any preservative could potentially interact with chemistry (e.g. very small molar quantities or hypersensitive bioassays).
Bacteriostatic water for injection (BAC water)
BAC water is SWFI with 0.9% w/v benzyl alcohol added as an antimicrobial preservative. Benzyl alcohol (C6H5CH2OH) is bacteriostatic — meaning it inhibits bacterial growth — at concentrations of 0.9–1.5%. This allows the reconstituted solution to be used multiple times over an extended period (typically 14–28 days at 2–8 °C) without microbial proliferation.
The key property: BAC water enables multi-day, multi-withdrawal use of a single reconstituted vial, dramatically reducing waste and improving experimental consistency across timepoints. For most research peptide protocols spanning more than a single day, BAC water is the default and correct choice.
When to use BAC water:
- Multi-day or multi-week research protocols requiring multiple withdrawals from a reconstituted vial;
- Peptide dosing studies where the same lot must be used across replicate timepoints;
- Combination studies where blend stability must be maintained;
- Default reconstitution for most lyophilized peptides — the supplier’s storage and reconstitution recommendations typically assume BAC water.
The benzyl alcohol consideration
Benzyl alcohol is a well-characterised preservative used in injectable pharmaceuticals since the 1940s. At the 0.9% concentration in BAC water, it is generally considered compatible with the majority of peptide chemistries. However, there are specific contexts where BAC water should not be used:
- Lipidated peptides at high concentration: some lipidated incretin analogues (e.g. tirzepatide, certain semaglutide analogues) may show foaming or aggregation when reconstituted in BAC water at high concentration. The amphipathic nature of the molecule and the surfactant-like behavior of benzyl alcohol can interact unfavourably. SWFI or 0.1% acetic acid may be preferred.
- Neonatal and very-low-volume applications: historically, “gasping syndrome” was observed in neonates given large doses of benzyl alcohol-preserved solutions. This is not relevant to typical in-vitro research but is a reason BAC water is not used in neonatal IV applications.
- Long-duration assays sensitive to benzyl alcohol metabolism: some cell culture studies require benzyl-alcohol-free reagents because the alcohol can be metabolised by cellular esterases to benzoic acid.
Practical comparison
Quality considerations for the diluent itself
Not all “BAC water” is created equal. When sourcing reconstitution solvents for research peptides:
- Verify the solvent is sourced from a reputable supplier with USP/EP-grade certification;
- Confirm the benzyl alcohol concentration is 0.9% (not 1.5% — sometimes called “preserved water for injection”);
- Check the expiration date on the vial; expired BAC water can have reduced antimicrobial efficacy;
- Store unopened BAC water at room temperature or 2–8 °C (per label); once opened, follow the 28-day rule.
References & further reading
- USP <1231> — Water for Pharmaceutical Purposes. United States Pharmacopeia.
- FDA. Compendial Compliance — Standards for Bacteriostatic water for Injection.
- Brown, W. J., Buist, N. R. M., Gipson, H. T. C., Huston, R. K., Kennaway, N. G. (1982). Fatal benzyl alcohol poisoning in a neonatal intensive care unit. The Lancet, 1(8283), 1250. DOI: 10.1016/S0140-6736(82)92389-0.
- Nair, B. (2001). Final report on the safety assessment of benzyl alcohol, benzoic acid, and sodium benzoate. International Journal of Toxicology, 20 Suppl 3, 23–50. DOI: 10.1080/10915810152630729.
- Akers, M. J. (2014). Sterile Drug Products: Formulation, Packaging, Manufacturing and Quality. CRC Press. DOI: 10.1201/b15813.
- Boylan, J. C., Cooper, J., Chowhan, Z. T. (1986). Handbook of Pharmaceutical Excipients. American Pharmaceutical Association.
- Strickley, R. G. (2004). Solubilizing excipients in oral and injectable formulations. Pharmaceutical Research, 21(2), 201-230. DOI: 10.1023/B:PHAM.0000016235.32639.23.
- Mottu, F., Laurent, A., Rüfenacht, D. A., Doelker, E. (2000). Organic solvents for pharmaceutical parenterals and embolic liquids. PDA Journal of Pharmaceutical Science and Technology, 54(6), 456-469.
- Wang, W. (2015). Tolerability of hypertonic injectables. International Journal of Pharmaceutics, 490(1-2), 308-315. DOI: 10.1016/j.ijpharm.2015.05.069.